|
US4058614A
(en)
*
|
1973-12-04 |
1977-11-15 |
Merck & Co., Inc. |
Substituted imidazole compounds and therapeutic compositions therewith
|
|
US4296122A
(en)
*
|
1975-07-09 |
1981-10-20 |
Merck & Co., Inc. |
2,3-Dihydro-6,7-disubstituted-5-(acyl)benzofuran-2-carboxylic acids
|
|
DE2707268A1
(de)
|
1977-02-19 |
1978-08-31 |
Hoechst Ag |
Indol-3-carbaldehyd-oxime und verfahren zu ihrer herstellung
|
|
DE2707269A1
(de)
|
1977-02-19 |
1978-08-24 |
Hoechst Ag |
Heterocyclische stickstoffverbindungen und verfahren zu ihrer herstellung
|
|
DE2707270A1
(de)
|
1977-02-19 |
1978-08-24 |
Hoechst Ag |
Pyrazolo-diazepine und verfahren zu ihrer herstellung
|
|
DE2727802A1
(de)
*
|
1977-06-21 |
1979-04-19 |
Hoechst Ag |
Sulfamoyl-arylketone und verfahren zu ihrer herstellung
|
|
JPS5936919B2
(ja)
|
1978-10-14 |
1984-09-06 |
日本新薬株式会社 |
インド−ル誘導体
|
|
DE3112116A1
(de)
|
1981-03-27 |
1982-11-04 |
Mundipharma GmbH, 6250 Limburg |
"arzneimittel"
|
|
US4510322A
(en)
*
|
1981-07-13 |
1985-04-09 |
Merck & Co., Inc. |
Indacrinone having enhanced uricosuric
|
|
DE3232922A1
(de)
|
1982-09-04 |
1984-03-08 |
Hoechst Ag, 6230 Frankfurt |
Sulfamoylbenzophenon-derivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
|
|
US4632930A
(en)
*
|
1984-11-30 |
1986-12-30 |
E. I. Du Pont De Nemours And Company |
Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
|
|
JPH0366669A
(ja)
|
1989-08-03 |
1991-03-22 |
Shionogi & Co Ltd |
複素環式化合物
|
|
DK0513379T3
(da)
*
|
1990-11-30 |
1996-09-30 |
Teijin Ltd |
2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne
|
|
WO1993004688A1
(en)
|
1991-09-09 |
1993-03-18 |
Warner-Lambert Company |
Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist
|
|
US5358961A
(en)
|
1991-11-30 |
1994-10-25 |
Jin Ro Limited |
Pyrrolidine derivatives
|
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
|
JPH07242694A
(ja)
|
1994-02-28 |
1995-09-19 |
Yamasa Shoyu Co Ltd |
トリアゾロプリンヌクレオシド誘導体及び該誘導体を製造するのに有用な合成中間体
|
|
US5514681A
(en)
*
|
1994-08-17 |
1996-05-07 |
Virginia Tech Intellectual Properties, Inc. |
Compositions and methods for controlling pest insects
|
|
US6037344A
(en)
*
|
1994-08-17 |
2000-03-14 |
Virginia Tech Intellectual Properties, Inc. |
Compositions and methods for controlling pest insects
|
|
US5770601A
(en)
*
|
1994-08-17 |
1998-06-23 |
Virginia Tech Intellectual Properties, Inc. |
Compositions and methods for controlling pest insects
|
|
AUPM835394A0
(en)
*
|
1994-09-23 |
1994-10-13 |
King, Michael G. Dr. |
Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
|
|
EP0811624A1
(en)
|
1995-02-21 |
1997-12-10 |
Yamasa Corporation |
Purine compounds and xanthine oxidase inhibitors
|
|
US6084147A
(en)
|
1995-03-17 |
2000-07-04 |
Studsvik, Inc. |
Pyrolytic decomposition of organic wastes
|
|
CA2190993C
(en)
|
1995-04-07 |
2004-06-01 |
Mikio Ota |
Protective agent for organ or tissue
|
|
ID21775A
(id)
*
|
1996-10-25 |
1999-07-22 |
Yoshitomi Pharmaceutical |
Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
|
|
US5965625A
(en)
*
|
1997-03-21 |
1999-10-12 |
King; Michael Glenn |
Compositions and methods for the control of smoking
|
|
JPH11140086A
(ja)
|
1997-11-07 |
1999-05-25 |
Yamasa Shoyu Co Ltd |
４−置換−１Ｈ−６−オキソピラゾロ［３，４−ｄ］ピリミジン化合物及びキサンチンオキシダーゼ阻害剤
|
|
US6191136B1
(en)
*
|
1997-11-07 |
2001-02-20 |
Johns Hopkins University |
Methods for treatment of disorders of cardiac contractility
|
|
CN1275126A
(zh)
*
|
1998-06-19 |
2000-11-29 |
帝人株式会社 |
2－(3－氰基－4－异丁氧基苯基)－4－甲基－5－噻唑甲酸的多晶型体及其制备方法
|
|
PL202799B1
(pl)
|
1998-08-06 |
2009-07-31 |
Mountain View Pharmaceuticals |
Sposób izolowania urykazy w postaci tetramerycznej oraz wyizolowana tetrameryczna urykaza
|
|
GB9824310D0
(en)
|
1998-11-05 |
1998-12-30 |
Univ London |
Activators of soluble guanylate cyclase
|
|
US6281222B1
(en)
*
|
1999-08-19 |
2001-08-28 |
Inotek Corporation |
Compositions and method for treatment of acetaminophen intoxication
|
|
JP2004517804A
(ja)
*
|
2000-06-28 |
2004-06-17 |
メルク・アンド・カンパニー・インコーポレーテッド |
心臓血管病の治療法
|
|
JP2002105067A
(ja)
*
|
2000-09-28 |
2002-04-10 |
Teijin Ltd |
２−フェニルチアゾール誘導体、およびそれを有効成分とする医薬組成物
|
|
ITMI20010206A1
(it)
|
2001-02-02 |
2002-08-02 |
Dompe Spa |
Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
|
|
BR0209133A
(pt)
*
|
2001-04-18 |
2004-06-15 |
Genzyme Corp |
Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
|
|
WO2002085380A1
(en)
*
|
2001-04-18 |
2002-10-31 |
Geltex Pharmaceuticals, Inc. |
Method for treating gout and reducing serum uric acid
|
|
CA2463441A1
(en)
|
2001-10-12 |
2003-05-08 |
Bayer Pharmaceuticals Corporation |
Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
|
|
NZ531673A
(en)
|
2002-01-28 |
2006-06-30 |
Fuji Yakuhin Co |
Novel 1,2,4-triazole compounds
|
|
US20060040945A1
(en)
*
|
2002-05-17 |
2006-02-23 |
Merckle Gmbh |
Annellated pyrrole compounds as proton pump inhibitors for treating ulcer
|
|
US7078423B2
(en)
|
2002-07-18 |
2006-07-18 |
Inotek Pharmaceuticals Corporation |
5-Aryltetrazole compounds, compositions thereof, and uses therefor
|
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
|
US20040122067A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Lin Zhao |
Treatment of chronic heart failure
|
|
US20040131676A1
(en)
*
|
2002-12-20 |
2004-07-08 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
|
WO2005018635A2
(en)
*
|
2003-08-07 |
2005-03-03 |
Cardiome Pharma Corp. |
Ion channel modulating activity i
|
|
WO2006028342A1
(en)
|
2004-09-06 |
2006-03-16 |
Biosynergen, Inc. |
A novel xanthine oxidase inhibitor and a pharmaceutical composition containing the same
|
|
WO2006055412A1
(en)
|
2004-11-19 |
2006-05-26 |
Shiva Biomedical, Llc |
Methods of treating erythropoietin-resistance
|
|
EP1883405A4
(en)
*
|
2005-05-09 |
2010-01-27 |
Takeda Pharmaceuticals North A |
METHODS OF TREATING NEPHROLITHIASIS
|
|
JP5242393B2
(ja)
|
2005-08-03 |
2013-07-24 |
タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド |
高血圧症の治療方法
|
|
US20090124623A1
(en)
*
|
2006-11-13 |
2009-05-14 |
Christopher Lademacher |
Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
|
|
KR20150024919A
(ko)
*
|
2006-11-13 |
2015-03-09 |
다케다 파마슈티칼스 유에스에이, 인코포레이티드 |
크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법
|
|
AU2008206231A1
(en)
|
2007-01-19 |
2008-07-24 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
|
|
MX2007011927A
(es)
|
2007-09-26 |
2009-03-26 |
World Trade Imp Export Wtie Ag |
Composiciones farmaceuticas que comprenden la combinacion de un agente antiinflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas.
|
|
US20100311756A1
(en)
*
|
2009-01-22 |
2010-12-09 |
Takeda Pharmaceuticals North America, Inc. |
Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
|
|
CA2812034C
(en)
*
|
2010-09-10 |
2018-10-23 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for concomitant treatment of theophylline and febuxostat
|